Free shipping on all orders over $ 500

GDC-0068 dihydrochloride

Cat. No. M5324

All AbMole products are for research use only, cannot be used for human consumption.

GDC-0068 dihydrochloride Structure
Synonym:

Ipatasertib dihydrochloride; RG-7440 dihydrochloride

Size Price Availability Quantity
5mg USD 110  USD110 In stock
10mg USD 160  USD160 In stock
50mg USD 430  USD430 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

In vitro: Testing against a broad panel of 230 kinases, GDC-0068 only inhibits 3 kinases by >70% at 1 μM concentration (PRKG1α, PRKG1β, and p70S6K, with IC50 of 98 nM, 69 nM, and 860 nM, respectively). GDC-0068 displays >100-fold selectivity for Akt over PKA with IC50 of 3.1 μM. In LNCaP, PC3 and BT474M1 cells, GDC-0068 treatment inhibits the phosphorylation of the Akt substrate, PRAS40 with IC50 of 157 nM, 197 nM, and 208 nM, respectively. Furthermore, GDC-0068 selectively inhibits cell cycle progression and viability of cancer cell lines driven by Akt signaling, including those with defects in the tumor suppressor PTEN, oncogenic mutations in PIK3CA, and amplification of HER2, with strongest effects in HER2+ and Luminal subtypes. In vivo: Oral administration of GDC-0068 in PC3 prostate tumor xenografts model induces down-regulation of p-PRAS40. In BT474-Tr xenografts, GDC-0068 treatment reduces pS6 and peIF4G levels, re-localizes FOXO3a to nucleus, and induces feedback upregulation of HER3 and pERK. Administration of GDC-0068 exhibits potent antitumor efficacy in multiple xenograft tumor models, including the PTEN-deficient prostate cancer models LNCaP and PC3, the PIK3CA H1047R mutant breast cancer model KPL-4, and MCF7-neo/HER2 tumor model.

Chemical Information
Molecular Weight 530.92
Formula C24H34Cl3N5O2
CAS Number 1396257-94-5
Solubility (25°C) DMSO 10 mM
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Yan Y, et al. Clin Cancer Res. Evaluation and clinical analyses of downstream targets of the Akt inhibitor GDC-0068.

[2] Lin J, et al. Clin Cancer Res. Targeting activated Akt with GDC-0068, a novel selective Akt inhibitor that is efficacious in multiple tumor models.

Related Akt Products
(E)-Akt inhibitor-IV

(E)-Akt inhibitor-IV is a PI3K-Akt inhibitor, with potent cytotoxic.

K-80003

K-80003 is a potent inhibitor of tRXRα-dependent Akt activation and cancer cell growth.

FPA-124 

FPA-124, a cell-permeable copper complex, is a selective Akt inhibitor with an IC50 of 0.1 μM.

SPOP-IN-1 

SPOP-IN-1 is a selective SPOP E3 ubiquitin ligase inhibitor.

10-DEBC hydrochloride 

10-DEBC hydrochloride is a selective Akt inhibitor, with an IC50 of 1.28 μM.

  Catalog
Abmole Inhibitor Catalog




Keywords: GDC-0068 dihydrochloride, Ipatasertib dihydrochloride; RG-7440 dihydrochloride supplier, Akt, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.